BTMD
biote Corp.
BTMD lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
BTMD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
BTMD's revenue, profitability, cash flow and balance sheet are all currently under pressure.
BTMD PE Valuation
BTMD has no meaningful PE right now: it lost money over the past year.
BTMD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect BTMD's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BTMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.16 | — |
| Q3 2026 | -$0.11 | -114% |
| Q2 2026 | $0.10 | -89% |
| Q1 2026 | $0.43 | -31% |
| Q4 2025 | $0.74 | +289% |
| Q3 2025 | $0.80 | +31% |
| Q2 2025 | $0.91 | +75% |
| Q1 2025 | $0.62 | +35% |
| Q4 2024 | $0.19 | +46% |
BTMD has swung to a loss: it lost $0.11 per share over the past year, after a profit the year before.
BTMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $43.3M | -9.6% |
| Q2 2026 | $44.2M | -9.5% |
| Q1 2026 | $44.9M | -8.3% |
| Q4 2025 | $46.4M | -6.9% |
| Q3 2025 | $48M | -6.7% |
| Q2 2025 | $48.9M | -0.6% |
| Q1 2025 | $49M | +4.7% |
| Q4 2024 | $49.8M | +9% |
BTMD's revenue has slid since its 2024 peak: $43M last quarter, down 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -12 points |
| Q2 2026 | -7.9% | -30 points |
| Q1 2026 | 7% | -13 points |
| Q4 2025 | 15% | +9.2 points |
| Q3 2025 | 17% | -6.5 points |
| Q2 2025 | 22% | +9.4 points |
| Q1 2025 | 20% | -2.5 points |
| Q4 2024 | 5.5% | -6.5 points |
BTMD's operating margin was 5.7% last quarter, down 11 points from the same quarter a year ago.
BTMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1M | -92% |
| Q2 2026 | -$3.7M | -171% |
| Q1 2026 | $3.5M | -27% |
| Q4 2025 | $6.5M | -39% |
| Q3 2025 | $13.6M | -3.1% |
| Q2 2025 | $5.3M | -29% |
| Q1 2025 | $4.8M | -27% |
| Q4 2024 | $10.7M | +50% |
BTMD still generates free cash flow, though less than at its 2024 peak: $7M over the past year.
BTMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.2% | -1.2M shares |
| 1 year | -25% | -9.3M shares |
| 3 years | -12% | -3.6M shares |
BTMD has 27M diluted shares, down 25% from a year ago, with $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.4M |
| Q2 2026 | $4.8M |
| Q1 2026 | $1.1M |
| Q4 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $1.5M |
| Q1 2024 | $4.1M |
BTMD spent $7M buying back its own shares over the past year.
BTMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.6x | High |
| Q2 2026 | 5.9x | High |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.9x | Healthy |
BTMD's net debt is about 8.6 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
BTMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.3 | Neutral |
| Stochastic | 6.0 | Oversold |
BTMD's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
BTMD PE vs Healthcare Sector
| Metric | BTMD | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 26x | 57% below |
| PE % | 73 | 36 | 37 pts above |
BTMD has no meaningful PE right now: it lost money over the past year.
BTMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.11 | 7.2% below |
| 20 week MA | $1.54 | 33% below |
| 50 week MA | $1.89 | 46% below |
| 100 week MA | $2.87 | 64% below |
| 200 week MA | $4.28 | 76% below |
BTMD is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
BTMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.1 | $9.85 | -2% |
| 2022 | $9.85 | $3.91 | -60% |
| 2023 | $3.91 | $4.94 | +26% |
| 2024 | $4.94 | $5.99 | +21% |
| 2025 | $5.99 | $2.68 | -55% |
| 2026 YTD | $2.68 | $1.03 | -62% |
BTMD has finished lower in three of the last five years. It's down 62% so far in 2026.